Abstract
Objective To investigate the presence and significance of Th9 cells and the related transcription factor (PU.1) and cytokine (IL-9) in peripheral blood of patents with hashimoto thyroiditis (HT). Methods Thirty patients with HT and thirty age/gender matched healthy subjects were recruited in this study. The peripheral blood and serum samples were collected from each subject. The percentages of Th9 cells and the transcriptional levels of PU.1 in peripheral blood mononuclear cells (PBMCs) were measured by flow cytometry analysis and real-time RT-PCR. The concentrations of IL-9, the functions of thyroid and the titers of thyroid-specific autoantibodies (TPOAb and TgAb) in serum samples were detected by using enzyme-linked immunosorbent assay (ELISA) and electrochemiluminescence immunoassay analysis (ECLIA). Results Compared with healthy subjects, the percentages of Th9 cells and the expression of PU.1 at mRNA level in PBMCs and the concentrations of IL-9 in serum samples were all significantly increased in patients with HT [(1.49±0.68)% vs (0.87±0.24)%], 4.91±2.14 vs 1.66±0.52, (26.90±7.74) pg/ml vs (16.71±5.87) pg/ml, all P<0.01). Serum concentrations of IL-9 were positively correlated with the percentages of Th9 cells (r=0.419, P=0.021). Moreover, the percentages of Th9 cells were positively correlated with the titers of TPOAb and TgAb in serum samples (r=0.394, P=0.032; r=0.457, P=0.011) of patients with HT. Conclusion The levels of Th9 cells and the related cytokine IL-9 were increased in the peripheral blood of patients with HT. A positive correlation was found between the percentage of Th9 cells and the titers of thyroid-specific autoantibodies. This study indicated that Th9 cells might be involved in the pathogenesis of autoimmune damage in thyroid. Key words: Hashimoto thyroiditis; Th9 cells; Interleukin 9; Thyroid; Autoimmunity
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.